Top 15. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other top dividend ...

Approximately 163 employees will be impacted by the pending closure of Merck’s Cherokee plant with layoffs set to begin in ...

As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the globa ...

DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the evolving Metabolic Dysfunction-Associated Steatohepatitis (MASH) market ...

Multi Use Bioreactor Market is Segmented by Type (Manual, Automatic, Semi-Automatic), by Application (Pharmaceuticals, Scientific Research Institution). According to new survey, Global Multi Use ...

As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.

Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...

NEW YORK CITY, NY / ACCESS Newswire / March 12, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

Merck has launched a $1 billion vaccine manufacturing facility in Durham, North Carolina, as part of a $12 billion U.S.

In a report released yesterday, Luisa Hector from Berenberg Bank maintained a Buy rating on Merck & Company (MRK – Research Report), with a ...

A federal judge has ruled in favor of Merck in litigation accusing the drugmaker of concealing the risks of Gardasil, a ...